Vir Biotechnology, Inc (VIR) insider trading
Every open-market stock purchase and sale by Vir Biotechnology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $20.9M over the last 12 months (37 sales). No open-market buys.
- Last insider buy: Charles Elliott Sigal (Director), $56.8K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $20.9M (37 sales). Last close $8.45 on Jun 7, 2026.
Recent VIR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | Timothy Coughlin (Director) | Bought (not open market) | — |
| Jun 9, 2026 | Timothy Coughlin (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Janet Napolitano (Director) | Sold | $30.2K |
| Jun 1, 2026 | Brent Sabatini (C-suite exec) | Sold | $3.6K |
| May 27, 2026 | Janet Napolitano (Director) | Bought (not open market) | — |
| May 27, 2026 | Norbert W Bischofberger (Director) | Bought (not open market) | — |
| May 27, 2026 | Robert J More (Director) | Bought (not open market) | — |
| May 27, 2026 | Ramy Farid (Director) | Bought (not open market) | — |
| May 27, 2026 | Janet Napolitano (Director) | Bought (not open market) | — |
| May 27, 2026 | Jeffrey S. Hatfield (Director) | Bought (not open market) | — |
| May 27, 2026 | Jeffrey S. Hatfield (Director) | Bought (not open market) | — |
| May 27, 2026 | Charles Elliott Sigal (Director) | Bought (not open market) | — |
| May 27, 2026 | Robert J More (Director) | Bought (not open market) | — |
| May 27, 2026 | Charles Elliott Sigal (Director) | Bought (not open market) | — |
| May 27, 2026 | Ramy Farid (Director) | Bought (not open market) | — |
| May 27, 2026 | Norbert W Bischofberger (Director) | Bought (not open market) | — |
| May 1, 2026 | Vicki L Sato (Director) | Sold | $221K |
| Apr 29, 2026 | Marianne De Backer (CEO) | Bought (not open market) | — |
| Apr 6, 2026 | Marianne De Backer (CEO) | Sold | $664K |
| Apr 1, 2026 | Vicki L Sato (Director) | Sold | $200K |
| Mar 23, 2026 | Brent Sabatini (C-suite exec) | Sold | $70.3K |
| Mar 20, 2026 | Jason O'Byrne (CFO) | Bought (not open market) | — |
| Mar 2, 2026 | Vicki L Sato (Director) | Sold | $207K |
| Mar 2, 2026 | Vicki L Sato (Director) | Sold | $2K |
| Feb 25, 2026 | Vanina de Verneuil (VP) | Sold | $135K |
Who's trading VIR
- Timothy Coughlin, Director: other filings, last Jun 9, 2026
- Janet Napolitano, Director: sold $30.2K (1 sale), last Jun 1, 2026
- Brent Sabatini, C-suite exec: sold $113K (5 sales), last Jun 1, 2026
- Norbert W Bischofberger, Director: other filings, last May 27, 2026
- Ramy Farid, Director: other filings, last May 27, 2026
- Jeffrey S. Hatfield, Director: other filings, last May 27, 2026
- Robert J More, Director: other filings, last May 27, 2026
- Charles Elliott Sigal, Director: other filings, last May 27, 2026
- Vicki L Sato, Director: sold $1.6M (10 sales), last May 1, 2026
- Marianne De Backer, CEO: sold $947K (3 sales), last Apr 29, 2026
- Jason O'Byrne, CFO: sold $68.9K (3 sales), last Mar 20, 2026
- Vanina de Verneuil, VP: sold $218K (5 sales), last Feb 25, 2026
- Mark Eisner, C-suite exec: sold $49.5K (3 sales), last Feb 25, 2026
- SVF Endurance (Cayman) Ltd, 10% owner: sold $17.8M (21 sales), last Dec 1, 2025
Get free alerts when an insider at Vir Biotechnology, Inc files a new trade →